Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1β, IL-2, IL-4, and IL-6: Possible involvement of dendritic cells

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1203-1209

  Saijo, Yasuo ^a   Hong, Xin ^a   Tanaka, Masashi ^a   Tazawa, Ryushi ^a   Liu, Shu Qin ^b   Saijo, Kaoru ^b   Ohno, Tadao ^b   Koike, Kaoru ^c   Ohkuda, Kazuhiro ^d   Satoh, Ken ^a   Nukiwa, Toshihiro ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c Miyagi Cancer Center   (Japan)

^d Miyagi Prefectural Semine Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032902310     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Somerfield, M. R. Clinical practice guideline for the treatment of unresectable non-small-cell lung cancer. J. Clin. Oncol., 15: 2996-3018, 1997.
2. Kradin, R. L., Kurnick, J. T., Lazarus, D. S., Preffer, F. I., Dubinett S. M., Pinto, C. E., Gifford, J., Davidson, E., Grove, B., Callahan, R. J., et al. Tumor-infiltrating lymphocytes and interleukin-2 treatment of advanced cancer. Lancet, 1: 577-580, 1989.
3. Van Der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
4. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
5. Peoples, G. E., Goedegebuure, P. S., Andrews, V. R., Schoof, D. D., and Eberlein, T. J. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunol., 151: 5481-5491, 1993.
6. Letessier, E. M., Heo, D. S., Okarma, T., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from blood and lymph nodes of patients with head and neck cancer. Cancer Res., 51: 3891-3899, 1991.
7. Linehan, D. C., Goedegebuure, P. S., Peoples, G. E., Rogers, S. O., and Eberlein, T. J. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. J. Immunol., 155: 4486-4491, 1995.
8. Slingluff, C. L., Cox, A. L., Stover, J. M., Moore, M. M., Hunt, D. F., and Engelhard, V. H. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res., 54: 2731-2737, 1994.
9. Yoshino, I., Goedegebuure, P. S., Peoples, G. E., Parikh, A. S., DiMaio, J. M., Lyerly, H. K., Gazdar, A. F., and Eberlein, T. J. HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res., 54: 3387-3390, 1994.
10. Liu, S. Q., Saijo, K., Todoroki, T., and Ohno, T. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nat. Med., 1: 267-271, 1995.
11. Tsurushima, H., Liu, S. Q., Tsuboi, K., Yoshi, Y., Nose, T., and Ohno, T. Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme. J. Neurosurg., 84: 258-263, 1996.
12. Stevenson, H., Gazdar, A. F., Phelps, R., Linnoila, I., Ihde, D. C., Ghosh, B., Walsh, T., Woods, E. L., Oie, H., O'Connor, T., et al. Tumor cell line established in vitro: an independent prognostic factor for survival in non-small-cell-lung cancer. Ann. Intern. Med., 113: 764-770, 1990.
13. Wunderlich, J., and Shearer, G. Induction, and measurement of cytotoxic T lymphocyte activity. In: Current Protocol in Immunology, 1991.
14. Saotome, K., Monta, H., and Umeda, M. Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs. Toxic In Vitro, 3: 317-321, 1989.
15. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyle/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor a. J. Exp. Med., 179: 1109-1118, 1994.
16. Foley, E. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res., 13: 835-837, 1953.
17. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R. M., and Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol., 14: 207-232, 1996.
18. Boon, T., and Van Der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
19. Nakao, M., Yamana, H., Imai, Y., Toh, Y., Toh, U., Kimura, A., Yanoma, S., Kakegawa, T., and Itoh, K. HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. Cancer Res., 55: 4248-4252, 1995.
20. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998.
21. Nestle, F. O., Alijajic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptideor tumor lysate-pulsed dendritic cells. Nat. Med, 4: 328-332, 1998.
22. Romani, N., Gruner, S., Brang, D., Kampgen, E., Leuz., A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83-93, 1994.
23. Vose, B. M., and Bonnard, G. D. Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. Nature (Lond.), 296: 359-361, 1982.
24. Vose, B. M., and Bonnard, G. D. Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2. Int. J. Cancer, 29: 33-39, 1982.
25. Kurnick, J. T., Kradin, R. L., Blumberg, R., Schneeberger, E. E., and Boyle, L. A. Functional characterization of T lymphocytes propagated from human lung carcinomas. Clin. Immunol. Immunopathol., 38: 367-380, 1986.
26. Seki, N., Hoshino, T., Kikuchi, M., Hayashi, A., and Itoh K. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer. Cell. Immunol., 175: 101-110, 1997.
27. Houghton, A. N. Cancer antigens:immune recognition of self and altered self. J. Exp. Med., 180: 1-4, 1994.
28. Kharkevitch, D. D., Seito, D., Balch, G. C., Maeda, T., Balch, C. M., and Itoh, K. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltration lymphocytes from a patients with metastatic melanoma. Int. J. Cancer, 58: 317-323, 1994.
29. Miyazaki, A., Sato, N., Takahashi, S., Sasaki, A., Kohama, G., Yamaguchi, A., Yagihash, A., and Kikuchi, K. Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4+ killer T cells against human autologous squamous cell carcinoma. Jpn. J. Cancer Res., 88: 191-197, 1997.
30. William, N. S., and Engelhard, V. H. Identification of a population of CD4+ CTL that utilizes a perforin-rather than a Fas ligand-dependent cytotoxic mechanism. J. Immunol., 156: 153-156, 1996.
31. Horn, G. T., Richards, B., and Klinger, K. W. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res., 17: 2140, 1989.